drugset / Trial / NCT01835314
Compassionate Use of Stiripentol in Dravet Syndrome
Summary
Compassionate use of Stiripentol in Dravet Syndrome. This is a treatment protocol, not a research study, therefore children will only be monitored on a clinical basis for seizure improvement predominantly by parent and caregiver report.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stiripentol | Small molecule | 5 mg/kg | Oral |
| Subject | Stiripentol | Small molecule | 50 mg/kg | Oral |